Diabetes


  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem recalls Mobi insulin pump, reports 230 adverse events

    A problem with a false occlusion alarm could interrupt insulin delivery for users, according to an entry in the FDA’s recall database.

    By • Nov. 11, 2026
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem Diabetes Care names next CEO

    Jeannette Bankes will take over the role from John Sheridan, who will retire at the end of the year after leading the company since 2019.

    By • Nov. 6, 2026
  • Three components of Johnson & Johnson's Ottava robotic surgery system are displayed. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed names David Segal chief medical officer

    Segal is succeeding Robert Vigersky, who is transitioning to a chief medical officer emeritus role ahead of his planned retirement at the end of next year.

    By • Nov. 5, 2026
  • Modern office building with tall glass windows and palm trees lining the entry drive. A large white and green sign in the foreground reads “Dexcom” with the number “6350” below. Surrounding the sign are colorful landscaping features including small bushes, flowers, and a mulched bed. Cars and flags are visible in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansion

    Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 diabetes. Competitor Dexcom, however, did not experience the same slowdown.

    By • Nov. 2, 2026
  • A white, rounded device is open showing clear tubing inside.
    Image attribution tooltip
    Permission granted by Sequel Medtech
    Image attribution tooltip

    FDA clears Sequel’s insulin delivery system in Type 2 diabetes

    With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.

    By • Oct. 19, 2026
  • A modern two-story commercial office building with a mix of gray and wood paneling on the exterior. Large glass windows dominate both floors, and the front entrance features the "Medtronic" logo above double glass doors. The surrounding area includes a few small shrubs and empty parking spaces in front.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    MiniMed completes separation from Medtronic

    Medtronic exchanged all of its remaining shares of the diabetes technology spinoff.

    By • Oct. 16, 2026
  • A person smiles and holds a spoon. A white patch is on their right upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    NEJM study supports CGM use for people with diabetes who don’t take insulin

    The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare coverage of the devices for people with Type 2 diabetes.

    By • Oct. 15, 2026
  • A person wears a white, oval device on their upper arm while their hair blows in the wind.
    Image attribution tooltip
    Permission granted by Sava Technologies
    Image attribution tooltip

    Ascensia leads $36M funding round for glucose sensor startup

    Ascensia also struck an exclusive sales agreement with Sava, which is making a wearable to continuously monitor glucose and other biomarkers.

    By • Oct. 12, 2026
  • Modern office building with tall glass windows and palm trees lining the entry drive. A large white and green sign in the foreground reads “Dexcom” with the number “6350” below. Surrounding the sign are colorful landscaping features including small bushes, flowers, and a mulched bed. Cars and flags are visible in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Dexcom gives CFO Jereme Sylvain expanded role

    Sylvain will work as chief operating officer of the diabetes technology company while continuing as its CFO.

    By • Sept. 16, 2026
  • A rectangular, plastic device sits on an adhesive patch.
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    Beta Bionics’ insulin patch pump gets FDA nod

    By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.

    By • Sept. 14, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic begins final steps to separate MiniMed

    The separation will allow Medtronic to focus on its cardiovascular, neuroscience and surgical portfolios, CEO Geoff Martha said.

    By • Sept. 14, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed submits new patch pump for FDA clearance

    The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop automated insulin delivery system.

    By • Sept. 1, 2026
  • Modern office building with tall glass windows and palm trees lining the entry drive. A large white and green sign in the foreground reads “Dexcom” with the number “6350” below. Surrounding the sign are colorful landscaping features including small bushes, flowers, and a mulched bed. Cars and flags are visible in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Dexcom, Abbott await Medicare coverage expansion for CGMs

    Dexcom CEO Jake Leach said he is watching for a decision by the federal health insurance program before the end of the year.

    By • Aug. 27, 2026
  • A round, white device is on a person's upper arm, below the sleeve of a pink shirt.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott receives FDA nod for dual-analyte sensor

    Abbott plans to roll out the device, called Libre Duo 10 Day, later this year. The sensor can measure both glucose and ketones.

    By • Aug. 25, 2026
  • Two children sitting on a blanket in a yard, eating snacks and having a picnic.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed starts shipping new insulin pump with Abbott-made sensor

    The company has begun a major marketing campaign to support the launch of its MiniMed Flex insulin pump.

    By • Aug. 24, 2026
  • A person holds a round, white device the size of a coin between their pointer finger and thumb.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Deep Dive

    5 questions on Abbott’s glucose-ketone sensors

    As Abbott prepares to launch its first dual-analyte sensor, endocrinologists talked to MedTech Dive about considerations for continuous ketone monitoring.

    By • Aug. 19, 2026
  • A person wears a round, black patch stuck to their upper arm. They hold a tiny cylinder between their thumb and pointer finger.
    Image attribution tooltip
    Courtesy of Senseonics
    Image attribution tooltip
    Q&A

    Inside Senseonics’ commercial overhaul and what’s next

    The diabetes tech firm recently brought its sales and marketing teams in-house after taking over commercialization of its device from Ascensia Diabetes Care.

    By • Aug. 13, 2026
  • A person eats oatmeal with berries, and a phone on the counter shows their current glucose levels.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott, Google to combine glucose data with AI coaching

    The multiyear partnership will connect Abbott’s over-the-counter Lingo sensor and the Google Health app. 

    By • Aug. 12, 2026
  • Modern office building with tall glass windows and palm trees lining the entry drive. A large white and green sign in the foreground reads “Dexcom” with the number “6350” below. Surrounding the sign are colorful landscaping features including small bushes, flowers, and a mulched bed. Cars and flags are visible in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    FDA names Dexcom as first participant in digital health pilot

    Selected devices will be exempt from certain premarket requirements while manufacturers collect real-world data through Medicare.

    By • July 23, 2026
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet launches Omnipod 5 in Spain

    A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.

    By • July 7, 2026
  • A person sits on a ledge with their legs in the water and eats. A patch is on their arm and a pen is on the ground next to food.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    MiniMed launches Abbott-made Instinct glucose sensor in Europe

    Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial year.

    By • June 24, 2026
  • Professional photo of Divakar Ramakrishnan.
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    Insulet hires first chief R&D officer amid growing competition

    Divakar Ramakrishnan brings experience from Convatec and Eli Lilly. Insulet said the new hire was an important step in strengthening the company’s innovation capabilities.

    By • June 23, 2026
  • A white, round device is stuck on a person's arm below their sleeve.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    4 diabetes tech execs on the future of multi-analyte glucose sensors

    Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.

    By • June 22, 2026
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    In a first, Dexcom’s OTC glucose sensor is cleared for kids

    The Stelo over-the-counter glucose monitor can now be used by children as young as two years.

    By • June 15, 2026
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Top medtech stories from ADA’s Scientific Sessions

    Dexcom, Abbott, MiniMed and Insulet featured upcoming technologies at the American Diabetes Association’s annual event. Catch up on news coming out of the conference.

    By • June 12, 2026